Lannett Co Inc Shares Outstanding 2006-2019 | LCI

Lannett Co Inc shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Lannett Co Inc Annual Shares Outstanding
(Millions of Shares)
2019 38
2018 38
2017 37
2016 37
2015 37
2014 35
2013 29
2012 28
2011 27
2010 25
2009 25
2008 24
2007 24
2006 24
2005 24
Lannett Co Inc Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 38
Q4 2019 38
Q3 2019 39
Q2 2018 39
Q1 2018 38
Q4 2018 38
Q3 2018 38
Q2 2017 38
Q1 2017 38
Q4 2017 37
Q3 2017 38
Q2 2016 38
Q1 2016 37
Q4 2016 37
Q3 2016 36
Q2 2015 37
Q1 2015 37
Q4 2015 37
Q3 2015 37
Q2 2014 37
Q1 2014 37
Q4 2014 35
Q3 2014 37
Q2 2013 36
Q1 2013 30
Q4 2013 29
Q3 2013 29
Q2 2012 28
Q1 2012 28
Q4 2012 28
Q3 2012 29
Q2 2011 29
Q1 2011 29
Q4 2011 27
Q3 2011 28
Q2 2010 26
Q1 2010 25
Q4 2010 25
Q3 2010 25
Q2 2009 25
Q1 2009 25
Q4 2009 25
Q3 2009 25
Q2 2008 25
Q1 2008 24
Q4 2008 24
Q3 2008 24
Q2 2007 24
Q1 2007 24
Q4 2007 24
Q3 2007 24
Q2 2006 24
Q1 2006 24
Q4 2006 24
Q3 2006 24
Q2 2005 24
Q1 2005 24
Q4 2005 24
Q3 2005 24
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.363B $0.655B
Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate themselves into certain specialty markets and achieve economies in production are all critical for their success in the generic pharmaceutical industry in which they operate. Lannett Company, Inc., continues to dedicate significant capital toward developing new products as they believe their success is linked to their ability to continually introduce new generic products into the marketplace.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $64.930B 10.26
Zoetis (ZTS) United States $57.313B 34.28
Astellas Pharma (ALPMY) Japan $31.713B 15.84
Eisai (ESALY) Japan $20.263B 39.07
UCB SA (UCBJF) Belgium $15.697B 0.00
Merck (MKGAF) Germany $15.483B 21.13
Grifols, S.A (GRFS) Spain $15.250B 19.46
Neurocrine Biosciences (NBIX) United States $10.382B 490.13
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.043B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.171B 16.55
Jazz Pharmaceuticals (JAZZ) Ireland $7.858B 10.04
Sage Therapeutics (SAGE) United States $7.667B 0.00
Catalent (CTLT) United States $7.478B 30.42
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.014B 18.02
Arrowhead Pharmaceuticals (ARWR) United States $4.788B 109.78
United Therapeutics (UTHR) United States $4.060B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.428B 12.53
FibroGen (FGEN) United States $3.285B 96.54
Nektar Therapeutics (NKTR) United States $3.221B 0.00
Evotec AG (EVTCY) Germany $3.079B 50.38
PTC Therapeutics (PTCT) United States $2.766B 0.00
Portola Pharmaceuticals (PTLA) United States $2.270B 0.00
Xencor (XNCR) United States $2.140B 65.05
Heron Therapeutics (HRTX) United States $2.089B 0.00
Zogenix (ZGNX) United States $2.022B 0.00
Tilray (TLRY) Canada $2.003B 0.00
Corcept Therapeutics (CORT) United States $1.938B 23.56
Ironwood Pharmaceuticals (IRWD) United States $1.803B 57.50
Pacira Pharmaceuticals (PCRX) United States $1.791B 52.99
USANA Health Sciences (USNA) United States $1.568B 16.73
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.238B 20.42
Radius Health (RDUS) United States $1.135B 0.00
ArQule (ARQL) United States $1.021B 0.00
Endo (ENDP) Ireland $1.009B 1.85
Theravance Biopharma (TBPH) Cayman Islands $0.991B 0.00
Karyopharm Therapeutics (KPTI) United States $0.980B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.949B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.909B 6.20
Aerie Pharmaceuticals (AERI) United States $0.874B 0.00
Organogenesis Holdings (ORGO) United States $0.754B 0.00
TherapeuticsMD (TXMD) United States $0.702B 0.00
Translate Bio (TBIO) United States $0.639B 0.00
Collegium Pharmaceutical (COLL) United States $0.638B 0.00
Flexion Therapeutics (FLXN) United States $0.628B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.573B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
ImmunoGen (IMGN) United States $0.521B 0.00
ChemoCentryx (CCXI) United States $0.505B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.465B 56.38
Aptorum Group (APM) Hong Kong, SAR China $0.457B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.449B 0.00
Ardelyx (ARDX) United States $0.445B 0.00
OptiNose (OPTN) United States $0.440B 0.00
Dermira (DERM) United States $0.439B 0.00
Siga Technologies (SIGA) United States $0.412B 9.41
BioSpecifics Technologies Corp (BSTC) United States $0.394B 16.98
Recro Pharma (REPH) United States $0.383B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.380B 0.00
Akebia Therapeutics (AKBA) United States $0.378B 0.00
Harpoon Therapeutics (HARP) United States $0.360B 0.00
DURECT (DRRX) United States $0.360B 0.00
Indivior (INVVY) United States $0.355B 1.28
Innate Pharma SA (IPHYF) France $0.340B 0.00
Molecular Templates (MTEM) United States $0.300B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.287B 0.00
Rafael Holdings (RFL) United States $0.282B 0.00
GlycoMimetics (GLYC) United States $0.264B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.224B 0.00
Xeris Pharmaceuticals (XERS) United States $0.216B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.208B 0.00
Calithera Biosciences (CALA) United States $0.208B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.207B 0.00
KalVista Pharmaceuticals (KALV) United States $0.203B 0.00
Nature's Sunshine Products (NATR) United States $0.188B 32.50
Avadel Pharmaceuticals (AVDL) Ireland $0.180B 0.00
Jounce Therapeutics (JNCE) United States $0.170B 2.28
Concert Pharmaceuticals (CNCE) United States $0.162B 0.00
Taiwan Liposome (TLC) Taiwan $0.162B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.158B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.139B 0.00
Aquestive Therapeutics (AQST) United States $0.136B 0.00
Ocular Therapeutix (OCUL) United States $0.135B 0.00
Redhill Biopharma (RDHL) Israel $0.132B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.130B 0.00
MEI Pharma (MEIP) United States $0.130B 0.00
CV Sciences (CVSI) United States $0.122B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
IMV INC (IMV) Canada $0.116B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.090B 0.00
MediWound (MDWD) Israel $0.085B 0.00
Majesco Entertainment (PTE) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 22.41
Otonomy (OTIC) United States $0.074B 0.00
Aclaris Therapeutics (ACRS) United States $0.073B 0.00
Pharmaxis (PXSLY) Australia $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.064B 0.00
Generex Biotechnology (GNBT) United States $0.062B 0.00
Infinity Pharmaceuticals (INFI) United States $0.060B 0.00
Champions Oncology (CSBR) United States $0.060B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.059B 0.00
Natural Alternatives (NAII) United States $0.059B 14.59
Genocea Biosciences (GNCA) United States $0.058B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
Medicure (MCUJF) Canada $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.054B 0.00
Novan (NOVN) United States $0.053B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Nivalis Therapeutics (ALPN) United States $0.048B 0.00
Capnia (SLNO) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.043B 0.00
CTI BioPharma (CTIC) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Mast Therapeutics (SVRA) United States $0.037B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Opexa Therapeutics (ACER) United States $0.033B 0.00
India Globalization Capital (IGC) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
Bio-Path Holdings (BPTH) United States $0.028B 0.00
IsoRay (ISR) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
PharmAthene (ALT) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Melinta Therapeutics (MLNT) United States $0.020B 0.00
Heat Biologics (HTBX) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Flex Pharma (SLRX) United States $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Lipocine (LPCN) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Vical (BBI) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.001B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00